Showing results (211-220 of 413) with videos related to

Sort By:
Pageof 42
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting SystemGiuseppe Cicala, Giulia Russo, Vincenza Santoro, et al.
Bioinformatics Advances|November 21, 2025
Exploring SARS-CoV-2 spike protein mutations through genetic algorithm-driven structural modelingValentina Di Salvatore, Avisa Maleki, Babak Mohajer, et al.
European Journal of Clinical Pharmacology|March 17, 2025
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting SystemMaria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala, et al.
Oncotarget|July 8, 2016
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53Valentina Pagliara, Assunta Saide, Emma Mitidieri, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 27, 2024
Late-Stage Functionalization Using a Popular Titrating Agent: Aryl-Chlorides and -Fluorides Activation by the Diphenylacetic Acid DianionAlessandro Cerveri, Giulia Russo, Sara Sparascio, et al.
Scientific Data|May 31, 2025
MSLesSeg: baseline and benchmarking of a new Multiple Sclerosis Lesion Segmentation datasetFrancesco Guarnera, Alessia Rondinella, Elena Crispino, et al.
International Journal of Molecular Sciences|December 30, 2020
S-Adenosyl-l-Methionine Overcomes uL3-Mediated Drug Resistance in p53 Deleted Colon Cancer CellsLaura Mosca, Martina Pagano, Annalisa Pecoraro, et al.
Biochimica Et Biophysica Acta. General Subjects|September 25, 2016
Backbone modified TBA analogues endowed with antiproliferative activityVeronica Esposito, Annapina Russo, Teresa Amato, et al.
NPJ Digital Medicine|November 17, 2025
Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologiesFrancesca Pistollato, Fabia Furtmann, Lindsay J Marshall, et al.
Cancers|March 29, 2023
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting SystemMaria Antonietta Barbieri, Emanuela Elisa Sorbara, Giulia Russo, et al.
Pageof 42